American Funds Corporate Bond C holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
American Funds Corporate Bond Fund Class C BFCCX
- NAV / 1-Day Return 9.41 / −0.32 %
- Total Assets 1.9B
-
Adj. Expense Ratio
1.440%
- Expense Ratio 1.440%
- Distribution Fee Level Below Average
- Share Class Type Level Load
- Category Corporate Bond
- Credit Quality / Interest Rate Sensitivity Medium/Moderate
- Min. Initial Investment 250
- Status Open
- TTM Yield 3.15%
- Effective Duration 6.70 years
USD | NAV as of Jun 18, 2026 | 1-Day Return as of Jun 18, 2026, 12:11 AM GMT+0
Morningstar’s Analysis BFCCX
Will BFCCX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the BFCCX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of BFCCX’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 9.8
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Capital Group Central Cash Fund | 4.27 | 83M | Cash and Equivalents |
United States Treasury Bonds 4.625% | 1.69 | 33M | Government |
United States Treasury Bonds 4.625% | 1.22 | 24M | Government |
AbbVie Inc. 5.05% | 1.18 | 23M | Corporate |
Morgan Stanley 4.356% | 1.03 | 20M | Corporate |
United States Treasury Notes 3.5% | 1.01 | 20M | Government |
Cash And Other Assets Less Liablities | 0.86 | 17M | Cash and Equivalents |
Chubb INA Holdings LLC 5% | 0.82 | 16M | Corporate |
Bank of America Corp. 5.045% | 0.77 | 15M | Corporate |
Abbott Laboratories 4.65% | 0.70 | 14M | Corporate |
United States